Brian Grabowski

ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease

Hing L. Sham, Dale J. Kempf, Akhteruzammen Molla et al. · Antimicrobial Agents and Chemotherapy · 1998 · 468 citations · Full text

Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus

Akhteruzzaman Molla, Sudthida Vasavanonda, Gondi Kumar et al. · Virology · 1998 · 177 citations

Protease Inhibitors, Biochemistry, Medicine +13

Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.

Jon F. Denissen, Brian Grabowski, Marianne K. Johnson et al. · PubMed · 1997 · 130 citations

Plasma Radioactivity, Pharmacotherapy, Antiviral Drug +17

Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans

Gondi Kumar, Venkata Jayanti, Marianne K. Johnson et al. · Pharmaceutical Research · 2004 · 105 citations

Medicine, Human Retrovirus, Antiviral Drug Development +7

Pharmacokinetics, Pharmacodynamics and Safety of Febuxostat, a Non-Purine Selective Inhibitor of Xanthine Oxidase, in a Dose Escalation Study in Healthy Subjects

Reza Khosravan, Brian Grabowski, Jingtao Wu et al. · Clinical Pharmacokinetics · 2006 · 104 citations

Healthy Subjects, Pharmacological Study, Pharmacology +6